Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

NASDAQ:RXRX   3:59:51 PM EDT
6.17
+0.45 (+7.87%)
Earnings Announcements

Recursion Provides Business Updates And Reports Q1 Financial Results

Published: 05/10/2022 21:43 GMT
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A (RXRX) - Recursion Provides Business Updates and Reports First Quarter 2022 Financial Results.
Recursion Pharmaceuticals Inc- Qtrly Loss per Share $0.33.
Revenue is expected to be $5.33 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $5.47 Million
Next Quarter EPS Guidance is expected to be -$0.40

More details on our Analysts Page.